Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -12.15%810M | -17.19%790M | 92.66%840M | 21.97%3.21B | 2.50%902M | 43.17%922M | 46.09%954M | -4.80%436M | -10.04%2.64B | -7.07%880M |
| Net income from continuing operations | -25.71%286M | -12.94%417M | 14.61%502M | 5.52%1.87B | -18.05%572M | 11.27%385M | 31.96%479M | 18.70%438M | -40.22%1.78B | 187.24%698M |
| Operating gains losses | 1,020.00%46M | -224.24%-107M | 9.30%-39M | 42.52%-173M | 38.85%-85M | -116.13%-5M | 75.74%-33M | 15.69%-43M | 80.84%-301M | -969.23%-139M |
| Depreciation and amortization | 4.33%241M | 7.08%257M | 49.36%233M | 30.02%862M | 32.02%235M | 40.85%231M | 44.58%240M | 0.65%156M | -2.93%663M | 9.88%178M |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---231M | ---- |
| Remuneration paid in stock | --0 | --0 | ---- | ---34M | --0 | --0 | ---34M | ---- | --0 | --0 |
| Remuneration paid in stock | -4.88%39M | --0 | 45.00%29M | 16.67%84M | -93.48%3M | 272.73%41M | 433.33%20M | -4.76%20M | -42.86%72M | -6.12%46M |
| Deferred tax | 25.84%112M | 122.92%116M | 50.55%137M | -137.29%-154M | 47.01%172M | -7.29%89M | -638.30%-506M | -14.15%91M | 66.53%413M | 34.48%117M |
| Other non cashItems | -5.52%137M | -82.79%133M | 102.94%69M | 240.06%1.08B | 54.55%119M | 107.14%145M | 481.20%773M | 9.68%34M | -21.34%317M | -21.43%77M |
| Change In working capital | -83.09%23M | -78.05%18M | 108.51%16M | 79.52%-43M | -235.19%-73M | 278.95%136M | 645.45%82M | 5.53%-188M | -218.64%-210M | -75.45%54M |
| -Change in other working capital | -83.09%23M | -78.05%18M | 108.51%16M | 79.52%-43M | -235.19%-73M | 278.95%136M | 645.45%82M | 5.53%-188M | -218.64%-210M | -75.45%54M |
| Dividends received (cash flow from operating activities) | -3.76%128M | 10.57%136M | -44.77%132M | -23.57%626M | -42.29%131M | -34.16%133M | -35.60%123M | 20.10%239M | 21.69%819M | -3.40%227M |
| Interest paid (cash flow from operating activities) | -0.58%-172M | -16.16%-115M | -58.04%-177M | -12.30%-502M | -22.45%-120M | -35.71%-171M | -2.06%-99M | 11.11%-112M | 0.00%-447M | 7.55%-98M |
| Tax refund paid | 51.61%-30M | 28.57%-65M | 68.84%-62M | -71.19%-404M | -6.12%-52M | 16.22%-62M | -37.88%-91M | -323.40%-199M | 29.34%-236M | -75.00%-49M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -12.15%810M | -17.19%790M | 92.66%840M | 21.97%3.21B | 2.50%902M | 43.17%922M | 46.09%954M | -4.80%436M | -10.04%2.64B | -7.07%880M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 8.41%-294M | 88.29%-341M | 36.59%-182M | -395.94%-3.91B | 11.66%-303M | -93.37%-321M | -2,175.78%-2.91B | -88.82%-287M | -412.34%-789M | -61.03%-343M |
| Capital expenditure reported | 32.06%-178M | 25.66%-197M | 6.45%-174M | -57.59%-955M | -36.72%-242M | -55.03%-262M | -115.45%-265M | -35.77%-186M | -0.17%-606M | -23.78%-177M |
| Net business purchase and sale | 12.90%-108M | 95.34%-126M | 52.43%-49M | -1,335.29%-2.93B | 100.61%1M | -675.00%-124M | -18,113.33%-2.7B | -171.05%-103M | -139.69%-204M | -211.32%-165M |
| Interest received (cash flow from investment activities) | -40.00%-7M | 40.00%-6M | 0.00%-6M | -73.33%-26M | 0.00%-5M | -25.00%-5M | -233.33%-10M | -100.00%-6M | 28.57%-15M | -66.67%-5M |
| Net other investing changes | -101.43%-1M | -118.75%-12M | 158.02%47M | -111.11%-4M | -1,525.00%-57M | 204.35%70M | 476.47%64M | -411.54%-81M | 185.71%36M | 128.57%4M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 8.41%-294M | 88.29%-341M | 51.60%-182M | -395.94%-3.91B | 11.66%-303M | -93.37%-321M | -2,175.78%-2.91B | -147.37%-376M | -412.34%-789M | -61.03%-343M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 22.37%-583M | -178.30%-386M | -142.89%-645M | 137.67%678M | -17.36%-568M | -66.89%-751M | 188.04%493M | 591.50%1.5B | 33.82%-1.8B | 48.07%-484M |
| Net issuance payments of debt | -50.00%-141M | -71.81%261M | -127.60%-186M | 897.67%1.37B | -54.02%-134M | -77.36%-94M | 919.47%926M | 732.10%674M | 76.94%-172M | -135.14%-87M |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | 84.98%-50M | --0 |
| Net preferred stock issuance | --0 | ---200M | ---26M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash dividends paid | -2.30%-445M | -3.23%-447M | -9.55%-436M | -7.73%-1.7B | -9.57%-435M | -9.57%-435M | -8.79%-433M | -2.84%-398M | 4.36%-1.58B | 22.46%-397M |
| Proceeds from stock option exercised by employees | --3M | --0 | --3M | 1,000.00%11M | --1M | --0 | 900.00%10M | --0 | -99.68%1M | --0 |
| Net other financing activities | ---- | ---- | ---- | --996M | --0 | ---222M | ---10M | --1.23B | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 22.37%-583M | -178.30%-386M | -142.89%-645M | 137.67%678M | -17.36%-568M | -66.89%-751M | 188.04%493M | 591.50%1.5B | 33.82%-1.8B | 48.07%-484M |
| Net cash flow | ||||||||||
| Beginning cash position | -17.97%210M | -90.98%155M | -6.62%141M | 41.12%151M | 5.05%104M | 265.71%256M | 1,520.75%1.72B | 41.12%151M | 148.84%107M | -67.86%99M |
| Current changes in cash | 55.33%-67M | 104.30%63M | -99.17%13M | -145.65%-21M | -41.51%31M | -635.71%-150M | -4,088.57%-1.47B | --1.56B | -16.36%46M | 126.77%53M |
| Effect of exchange rate changes | 400.00%6M | -300.00%-8M | -66.67%1M | 650.00%11M | 700.00%6M | -300.00%-2M | 500.00%4M | 400.00%3M | -122.22%-2M | 66.67%-1M |
| End cash Position | 43.27%149M | -17.97%210M | -90.98%155M | -6.62%141M | -6.62%141M | 5.05%104M | 265.71%256M | 1,520.75%1.72B | 41.12%151M | 41.12%151M |
| Free cash from | -4.24%632M | -13.93%593M | 166.40%666M | 11.34%2.26B | -6.12%660M | 38.95%660M | 30.00%689M | -22.12%250M | -12.69%2.03B | -12.56%703M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.